This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a scheduled system of the Kaiser Family Foundation, a nonpartisan healthcare policy research firm unaffiliated with Kaiser Permanente. Â.. Al Jazeera system examines politics of global food security In an bout of Al Jazeera's ‘Inside Story,’ presenter Shiulie guests and Ghosh Chandra Bhushan, a climate switch deputy and scientist director of the Center for Science and Environment; Deborah Doane, the director of the World Development Movement and an expert on corporate power who also blogs on meals politics; and Philip Thornton of the Consultative Group on International Agricultural Research examine the politics of global food protection.Development: Sticking to thalidomide The sedative and morning-sickness medication thalidomide was withdrawn in 1961 after doctors observed that it triggered multiple birth defects, including limb, ear, heart and gut malformations. In recent years, the drug offers been reintroduced under stringent control for different indications, such as for example cancer. Yet despite almost half a century of research, most of the molecular targets underlying the developmental defects due to thalidomide stay unclear. This March, Japanese scientists identified a protein called cereblon to which thalidomide binds. Today, thalidomide can be used to treat people with multiple myeloma and leprosy clinically, so understanding the molecular targets of thalidomide and their roles in limb formation can help produce safer derivatives of the drug.